Purchases and Sales Made in Q2 2023 in Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN) during Q2 2023. The information is specifically focused on institutions that hold shares of NeuroSense Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
1.27MNew |
$1.82M - $2.68M
|
1.27M
$1.41M
|
|
|
Aug 14, 2023
Q2 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
- |
100KNew |
$144K - $212K
|
100K
$111K
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
1.3KNew |
$1.88K - $2.76K
|
1.3K
$1.45K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|